MTOR and tuberous sclerosis: Considering the therapy of mTOR inhibitors is always in need of long-term use in TSC patients, it is necessary to investigate the long-term efficacy and safety of mTOR inhibitors on TSC-associated RAH (Tran and Zupanc, 2015).